Drug Discovery Informatics Market by Solutions, Functions, End-User, Application

Description

List of Tables

[189 Pages Report] The Drug Discovery Informatics Market size was estimated at USD 2.90 billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 9.92% to reach USD 5.64 billion by 2030.

Global Drug Discovery Informatics Market

KEY MARKET STATISTICS
Base Year [2023]	USD 2.90 billion
Estimated Year [2024]	USD 3.19 billion
Forecast Year [2030]	USD 5.64 billion
CAGR (%)	9.92%

Drug Discovery Informatics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Discovery Informatics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Discovery Informatics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Informatics Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Agilent Technologies, Inc., Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Cadence Design Systems, Inc., Certara, Inc., Charles River Laboratories International, Inc., ChemAxon Ltd., Cognizant Technology Solutions Corporation, Collaborative Drug Discovery, Inc, Crown Bioscience, Inc., Dassault Systemes SE, Eurofins DiscoverX Products LLC, Evotec AG, Illumina, Inc., Infosys Limited, InSilico Medicine, International Business Machines Corporation, Jubilant Biosys Ltd., Oracle Corporation, PerkinElmer Inc., Schrodinger, Inc., Selvita S.A., Thermo Fisher Scientific Inc., and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Informatics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Solutions
- Services
- Software
Functions
- Docking
- Libraries & Database Preparation
- Molecular Modeling
- Sequencing & Target Data Analysis
End-User
- Contract Research Organizations (CRO)
- Pharmaceutical & Biotechnology Companies
Application
- Drug Development
  - Clinical Trials
  - Preclinical Testing
- Drug Discovery
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Drug Discovery Informatics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Discovery Informatics Market?

3. What are the technology trends and regulatory frameworks in the Drug Discovery Informatics Market?

4. What is the market share of the leading vendors in the Drug Discovery Informatics Market?

5. Which modes and strategic moves are suitable for entering the Drug Discovery Informatics Market?

Product Code: MRR-521BAA36EBE2

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Drug Discovery Informatics Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing need for precision medicine in rare and orphan disease management
  - 5.1.1.2. Favorable government support for drug discovery procedures
  - 5.1.1.3. Rising use of bioinformatic software for drug discovery and development
- 5.1.2. Restraints
  - 5.1.2.1. Involvement of huge cost for development of bio-informatic infrastructure
- 5.1.3. Opportunities
  - 5.1.3.1. Potential research investments for the development of drug discovery informatics
  - 5.1.3.2. Integration of next-generation technologies in drug discovery procedures
- 5.1.4. Challenges
  - 5.1.4.1. Lack of skilled and experienced professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Drug Discovery Informatics Market, by Solutions

6.1. Introduction
6.2. Services
6.3. Software

7. Drug Discovery Informatics Market, by Functions

7.1. Introduction
7.2. Docking
7.3. Libraries & Database Preparation
7.4. Molecular Modeling
7.5. Sequencing & Target Data Analysis

8. Drug Discovery Informatics Market, by End-User

8.1. Introduction
8.2. Contract Research Organizations (CRO)
8.3. Pharmaceutical & Biotechnology Companies

9. Drug Discovery Informatics Market, by Application

9.1. Introduction
9.2. Drug Development
- 9.3.1. Clinical Trials
- 9.3.2. Preclinical Testing
9.3. Drug Discovery

10. Americas Drug Discovery Informatics Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Drug Discovery Informatics Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Informatics Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Accenture PLC
- 14.1.2. Agilent Technologies, Inc.
- 14.1.3. Aragen Life Sciences Ltd.
- 14.1.4. Boehringer Ingelheim International GmbH
- 14.1.5. Cadence Design Systems, Inc.
- 14.1.6. Certara, Inc.
- 14.1.7. Charles River Laboratories International, Inc.
- 14.1.8. ChemAxon Ltd.
- 14.1.9. Cognizant Technology Solutions Corporation
- 14.1.10. Collaborative Drug Discovery, Inc
- 14.1.11. Crown Bioscience, Inc.
- 14.1.12. Dassault Systemes SE
- 14.1.13. Eurofins DiscoverX Products LLC
- 14.1.14. Evotec AG
- 14.1.15. Illumina, Inc.
- 14.1.16. Infosys Limited
- 14.1.17. InSilico Medicine
- 14.1.18. International Business Machines Corporation
- 14.1.19. Jubilant Biosys Ltd.
- 14.1.20. Oracle Corporation
- 14.1.21. PerkinElmer Inc.
- 14.1.22. Schrodinger, Inc.
- 14.1.23. Selvita S.A.
- 14.1.24. Thermo Fisher Scientific Inc.
- 14.1.25. WuXi AppTec Co., Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing